Search - tctmd.com

Displaying 381 - 400 of 6832

Sort: Relevancy | Date

Presentation NY Valves 2025

Balloon Rupture During Redo-TAVR Using Sapien 3 Ultra Resilia in Failed Evolut R

Presenter: Takayuki Onishi

June 26, 2025

Presentation NY Valves 2025

The INFLOW TAVR System: Polymeric and Biological Designs with a Unique Self-Positioning Delivery System

Presenter: Piotr P. Buszman

June 26, 2025

Presentation NY Valves 2025

CT Analysis of Valve Frame Expansion in Patients Undergoing Redo TAVR: A First-in-Human Experience

Presenter: Parasuram Krishnamoorthy

June 26, 2025

Presentation NY Valves 2025

Needlestick Prevention During TAVR Procedures Using Left Ventricular Pacing

Presenter: Kimberly Humiston

June 26, 2025

Presentation NY Valves 2025

Late Coronary Obstruction After TAVR

Presenter: Itsik Ben-Dor

June 26, 2025

Presentation NY Valves 2025

SIEGEL TAVR: Technology Update and EFS Results (Mirus Medical)

Presenter: Raj Makkar

June 26, 2025

Presentation NY Valves 2025

TAVR Surprise: When Calcium Strikes Back – A Case of Intermittent Coronary Obstruction

Presenter: Salman Zahid

June 26, 2025

Presentation NY Valves 2025

Acute Fracture of a Self-Expanding Transcatheter Aortic Valve After Balloon Dilatation

Presenter: Annette Maznyczka

June 26, 2025

Presentation NY Valves 2025

Terminology and Important Design Features and Second Valve Options

Presenter: Gilbert H. L. Tang

June 26, 2025

Presentation NY Valves 2025

Prognostic Value of Baseline Aortic Valve Gradient in Acute Heart Failure Patients Undergoing TAVR

Presenter: Nirat Beohar

June 26, 2025

Presentation NY Valves 2025

Novel Balloon-Expandable Transcatheter Heart Valve for Aortic Stenosis: Insights from the First-In-Human Series (Abbott)

Presenter: Susheel K. Kodali

June 26, 2025

Presentation NY Valves 2025

Management of Valve Balloon Rupture: a Case-Based Tutorial

Presenter: Itsik Ben-Dor

June 26, 2025

Presentation NY Valves 2025

Fluoroscopic Evaluation of Sapien 3 Movement in Short-in-Tall Redo-TAVR: A First-in-Human Analysis

Presenter: Takayuki Onishi

June 26, 2025

Presentation NY Valves 2025

Redo TAVR Using SAPIEN 3 in Degenerated ACURATE Neo

Presenter: Chloe Kharsa

June 26, 2025

Presentation NY Valves 2025

Percutaneous or Surgical Trans-Axillary Access for TAVR With Hostile Femoral Access: Insights From the HOSTILE Registry

Presenter: Matteo Sturla

June 26, 2025

Presentation NY Valves 2025

Balloon Assisted Shortening of TAVR Valve: Reducing Risk of Coronary Obstruction

Presenter: Yasemin Ciftcikal

June 26, 2025

Presentation NY Valves 2025

Optimizing Outflow During Redo-TAVR With a 23 mm Sapien UR for a Degenerated Evolut PRO 26 mm Valve

Presenter: Srivatsan Swaminathan

June 26, 2025

Presentation NY Valves 2025

Keynote: The Case for Tandem or Staged AF Ablation and LAAC: Beyond OPTION

Presenter: Rodney Horton

June 26, 2025

Presentation NY Valves 2025

Surgical vs. Medical Treatment of Post-TAVR Endocarditis: A Meta-Analysis of Outcomes and Insights From Contemporary Cohorts

Presenter: Dimitrios Magouliotis

June 26, 2025

Presentation NY Valves 2025

LAAC After TAVR: Key Lessons From WATCH TAVR

Presenter: Samir R. Kapadia

June 26, 2025

Advertisement

Balloon Rupture During Redo-TAVR Using Sapien 3 Ultra Resilia in Failed Evolut R

The INFLOW TAVR System: Polymeric and Biological Designs with a Unique Self-Positioning Delivery System

CT Analysis of Valve Frame Expansion in Patients Undergoing Redo TAVR: A First-in-Human Experience

Needlestick Prevention During TAVR Procedures Using Left Ventricular Pacing

Late Coronary Obstruction After TAVR

SIEGEL TAVR: Technology Update and EFS Results (Mirus Medical)

TAVR Surprise: When Calcium Strikes Back – A Case of Intermittent Coronary Obstruction

Acute Fracture of a Self-Expanding Transcatheter Aortic Valve After Balloon Dilatation

Terminology and Important Design Features and Second Valve Options

Prognostic Value of Baseline Aortic Valve Gradient in Acute Heart Failure Patients Undergoing TAVR

Novel Balloon-Expandable Transcatheter Heart Valve for Aortic Stenosis: Insights from the First-In-Human Series (Abbott)

Management of Valve Balloon Rupture: a Case-Based Tutorial

Fluoroscopic Evaluation of Sapien 3 Movement in Short-in-Tall Redo-TAVR: A First-in-Human Analysis

Redo TAVR Using SAPIEN 3 in Degenerated ACURATE Neo

Percutaneous or Surgical Trans-Axillary Access for TAVR With Hostile Femoral Access: Insights From the HOSTILE Registry

Balloon Assisted Shortening of TAVR Valve: Reducing Risk of Coronary Obstruction

Optimizing Outflow During Redo-TAVR With a 23 mm Sapien UR for a Degenerated Evolut PRO 26 mm Valve

Keynote: The Case for Tandem or Staged AF Ablation and LAAC: Beyond OPTION

Surgical vs. Medical Treatment of Post-TAVR Endocarditis: A Meta-Analysis of Outcomes and Insights From Contemporary Cohorts

LAAC After TAVR: Key Lessons From WATCH TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content